Private equity

Private Equity

Skillful Investment in late-stage companies allows NEMO to capture exceptional value

Launched at the end of 2007, the New Emerging Medical Opportunities (NEMO) strategy is focused on companies involved in the development of new pharmaceuticals, medical technology devices and related products to serve the global healthcare market.

Investment Strategy

Differentiated approach to private healthcare investing

Investing to achieve


Fund level return in

2-4 years

Synergistic Expertise

Sectoral Private Equity Porfolio

NEMO Private Investment Team & Industry Partners

Sectoral's investment philosophy is based on fundamental research in the healthcare sector. This means that our investment team must have multiple areas of expertise. Sectoral's investment professionals have managed healthcare/biotechnology portfolios for over nineteen years. Most members of our team are CFA charterholders or candidates and most have earned postgraduate degrees in both business and science.